Health ❯Medicine ❯Pharmaceuticals

Weight Loss

Ozempic Clinical Trials GLP-1 Drugs Mounjaro Semaglutide GLP-1 Agonists Obesity Tirzepatide Orforglipron GLP-1 Medications Prescription Medications Drugs Retatrutide Effectiveness Comparison Drug Comparison Wegovy Amycretin Weight Loss Jabs Slimming Injections Weight Loss Medications Drug Safety Pregnancy

Wegovy Sales Soar as UK Mounjaro Price Jumps 170%

Private demand is pivoting to cheaper alternatives, prompting renewed warnings over black‑market jabs.

Amgen Advances Monthly Obesity Drug to Phase 3 After 20% Weight Loss in Mid-Stage Trial

New Oral β2 Agonist Preserves Muscle in Early Weight-Loss Trials

Eli Lilly’s Oral GLP-1 Pill Matches Injectables in Weight and Blood Sugar Control

Germany Faces Surge in Forged Prescriptions for Weight Loss Injections

Three Arrested After Unlicensed Weight-Loss Jab Leaves Woman Hospitalized

‘Ozempic Teeth’ Emerges as a Serious Dental Risk for Weight-Loss Drug Users

Three Arrested in Selby Over Illegal Slimming Injections After Woman's Hospitalisation

‘Ozempic Mouth’ Identified as New Cosmetic Concern for Weight-Loss Drug Users

Novo Nordisk Faces Investor Turmoil as Wegovy Sales and Market Share Decline

Amy Schumer Embraces Mounjaro and Hormone Therapy for Improved Health

Rising Use of Ozempic Raises Health, Ethical, and Social Concerns

Amgen's Weight-Loss Drug Shows Promise but Faces Investor Skepticism

James Corden Reveals Ozempic Failed to Address His Food Addiction

Novo Nordisk's Amycretin Pill Shows Promising Weight Loss Results in Early Trial

Eli Lilly's Mounjaro Outperforms Novo Nordisk's Ozempic in Weight Loss Study

Study Reveals Wegovy Yields Greater Weight Loss in Women with Heart Failure

Weight-Loss Drug Tirzepatide Shows Promise for Treating Sleep Apnea

New Study Reveals Gradual Reduction of Ozempic Prevents Weight Rebound

Kate Winslet Criticizes Ozempic, Opens Up About Past Eating Disorder